Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
| ▸ | ADRB2 | P07550 | 4/20 | 0.50 |
| ▸ | ADRB1 | P08588 | 4/20 | 0.50 |
| ▸ | ADRB3 | P13945 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7988568 | 0.88 | GAA (0.54) | GAATSHRLMNAMAPTPOLB | |
| SCHEMBL27929357 | 0.88 | KMT2A (0.60) | GAATSHRLMNAMAPTPOLB | |
| SCHEMBL9369918 | 0.87 | MAPT (0.62) | GAATSHRLMNAMAPTPOLB | |
| SCHEMBL28317169 | 0.83 | LMNA (0.68) | GAATSHRLMNAMAPTPOLB | |
| SCHEMBL11460576 | 0.83 | PLA2G4B (0.58) | TSHRLMNAMAPTPOLBNPSR1 | |
| SCHEMBL948187 | 0.81 | GAA (0.62) | GAATSHRLMNAMAPTPOLB | |
| SCHEMBL4983780 | 0.81 | ADRB2 (0.55) | MAPTADRB2ADRB1ADRB3ALDH1A1 | |
| SCHEMBL110051 | 0.80 | ALDH1A1 (0.64) | TSHRMAPTADRB2ADRB1ADRB3 | |
| SCHEMBL2179812 | 0.80 | ADRB2 (0.69) | MAPTADRB2ADRB1ADRB3ALDH1A1 | |
| SCHEMBL2179816 | 0.80 | ADRB2 (0.69) | MAPTADRB2ADRB1ADRB3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3389620-A1 | STEM CELL STIMULATING COMPOSITIONS AND METHODS OF TREATING MELASMA | Medicell Technologies, LLC (US) | 2018-10-24 | — | — | EP | disclosed |
| WO-2017105413-A1 | STEM CELL STIMULATING COMPOSITIONS AND METHODS OF TREATING MELASMA | MEDICELL TECHNOLOGIES, LLC (US) | 2017-06-22 | — | — | WO | disclosed |
| EP-1753387-A4 | COFFEE CHERRY COSMETIC COMPOSITIONS AND METHODS | VDF FUTURECEUTICALS INC (US) | 2009-07-29 | — | — | EP | disclosed |
| EP-1753387-A2 | COFFEE CHERRY COSMETIC COMPOSITIONS AND METHODS | VDF Futureceuticals, Inc. (US) | 2007-02-21 | — | — | EP | disclosed |
| WO-2005102373-A2 | COFFEE CHERRY COSMETIC COMPOSITIONS AND METHODS | VDF FUTURECEUTICALS, INC. (US) | 2005-11-03 | — | — | WO | disclosed |